$PLRX
Pliant Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.13
▲+5.61%+$0.060
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePliant Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is PLRX up today? It is at $1.13 (+5.61%), and our scanner flagged it 18 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PLRX spikes, and full due diligence on PLRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PLRX 18 times in the last 30 days. Create a free account to track $PLRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on PLRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PLRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kuo Minnie Officer | Sold (automatic/other) | -7K 0.01% of company | sold 15% | 38K | $9K at $1.28 | Jan 20, 26 |
Cheung Lily Officer | Sold (automatic/other) | -8K 0.01% of company | sold 14% | 45K | $10K at $1.28 | Jan 20, 26 |
Coulie Bernard Officer | Sold (automatic/other) | -89K 0.1% of company | sold 15% | 506K | $114K at $1.28 | Jan 20, 26 |
Cummings Keith Lamont Officer | Sold (automatic/other) | -24K 0.04% of company | sold 7.5% | 297K | $31K at $1.28 | Jan 20, 26 |
Cheung Lily Officer | Acquired (grant/award) | +26K 0.04% of company | added 100% | 50K | n/a | Jan 23, 25 |
Coulie Bernard Officer | Acquired (grant/award) | +163K 0.3% of company | added 38% | 593K | n/a | Jan 23, 25 |
Cummings Keith Lamont Officer | Acquired (grant/award) | +57K 0.09% of company | added 22% | 319K | n/a | Jan 23, 25 |
Lefebvre Eric Officer | Acquired (grant/award) | +46K 0.07% of company | added 23% | 240K | n/a | Jan 23, 25 |
Hull Hans Officer | Acquired (grant/award) | +40K 0.06% of company | added 19% | 252K | n/a | Jan 23, 25 |
Ouimette Mike Officer | Acquired (grant/award) | +35K 0.06% of company | added 50% | 106K | n/a | Jan 23, 25 |
Ouimette Mike Officer | Sold (automatic/other) | -10K 0.02% of company | sold 13% | 71K | $112K at $10.99 | Jan 22, 25 |
Ouimette Mike Officer | Sold (automatic/other) | -13K 0.02% of company | sold 14% | 81K | $149K at $11.20 | Jan 17, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on PLRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PLRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
PLRX last traded at $1.13, up 5.61% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Pliant Therapeutics, Inc. Common Stock (PLRX) is next expected to report earnings on Thursday, November 5, 2026, about 49 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PLRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PLRX 18 times in the last 30 days.
PLRX (Pliant Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $66M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PLRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PLRX discussion
Sign in to ask a question or join the discussion.